ScholarIQanswers from OpenAlex

Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome

PaperCitations, authors & open-access status

Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome have?

ScholarIQcitation count

Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome has 1,038 citations in the OpenAlex counts ScholarIQ stores.

When was Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome published?

ScholarIQyear

Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome has 2013 year in the ScholarIQ index.

What is the open-access status of Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome?

ScholarIQoa status

Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome has green oa status in the ScholarIQ index.

What is the DOI of Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome?

ScholarIQdoi

The DOI for Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome is on the source record.

What is the PMID of Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome?

ScholarIQpmid

The PMID for Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome is on the source record.

What is the OpenAlex record for Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome?

ScholarIQopenalex

The OpenAlex for Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial